Journal
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume 38, Issue -, Pages E1332-E1340Publisher
WILEY-BLACKWELL
DOI: 10.1002/hed.24224
Keywords
nasopharyngeal carcinoma; hematologic markers; neutrophil-lymphocyte ratio; platelet-lymphocyte ratio; prognosis
Categories
Funding
- National Natural Science Foundation of China [81272491]
Ask authors/readers for more resources
Background. Pretreatment hematological markers of inflammatory response have emerged as prognostic factors for patients with cancer. In this study, we evaluated the prognostic significance of various hematologic parameters in patients with nasopharyngeal carcinoma (NPC). Methods. Clinical data from 251 patients with NPC were retrospectively collected. Neutrophil counts, lymphocyte counts, platelet counts, neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR) were adopted as potential prognostic biomarkers. The Kaplan-Meier method and log-rank test were adopted to calculate and compare the progression-free survival (PFS) and overall survival (OS) rates. The Cox proportional hazards model was used to carry out univariate and multivariate analyses. Results. NLR >= 2.7 (hazard ratio[HR] = 2.01; 95% confidence interval [CI] 51.23-3.29; p=.005) and PLR >= 167.2 (HR=2.12; 95% CI=1.35-3.33; p=.001) were significantly associated with shorter PFS, whereas PLR >= 163.4 (HR=2.64; 95% CI=1.25-5.60; p=.011) was correlated with poor OS. Conclusion. Pretreatment NLR and PLR can be independent prognostic factors for patients with NPC. (C) 2015 Wiley Periodicals,
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available